Evidence map›Paper›PMID 17088532›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Wilms' tumor 1-associating protein regulates G2/M transition through stabilization of cyclin A2 mRNA.

Keiko Horiuchi, Michihisa Umetani, Takashi Minami, Hiroto Okayama, Shinji Takada, Masayuki Yamamoto, Hiroyuki Aburatani, Patrick C Reid, David E Housman, Takao Hamakubo and 1 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. The N6-methyladenosine (mBritish journal of haematology · 2026
    Article
  3. WTAP tetramer ensures mEMBO reports · 2026
    Article
  4. mMolecular medicine reports · 2026
    Review
  5. WTAP mediated mScience China. Life sciences · 2026
    Article
  6. WTAP-induced mCell biochemistry and biophysics · 2025
    Article
  7. WTAP-mediated mHuman cell · 2025
    Article
  8. Impact of NbioRxiv : the preprint server for biology · 2025
    Article
  9. Article
  10. Targeting RNA adenosine editing and modification enzymes for RNA therapeutics.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Keiko HoriuchiLaboratory for Systems Biology and Medicine, Research Center for Advanced Science and Technology, University of Tokyo, Meguro, Tokyo 153-8904, Japan.
Michihisa Umetani
Takashi Minami
Hiroto Okayama
Shinji Takada
Masayuki Yamamoto
Hiroyuki Aburatani
Patrick C Reid
David E Housman
Takao Hamakubo
Tatsuhiko Kodama
Center for Systems Biology · USThe University of Tokyo · JPMassachusetts Institute of Technology · USNational Institutes of Natural Sciences · JPThe University of Texas Southwestern Medical Center · USUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilms' tumor 1-associating protein (WTAP) has been reported to be a ubiquitously expressed nuclear protein. Although a relation to splicing factors has been postulated, its actual physiological function still remains to be elucidated. To investigate the role of WTAP, we generated WTAP-knockout mice and performed small interfering RNA (siRNA)-mediated knockdown analyses in primary cultured cells. In DNA microarrays using human umbilical vein endothelial cells, WTAP-targeted siRNA treatment resulted in markedly reduced expression of cell-cycle-related genes. siRNA-mediated WTAP knockdown down-regulated the stability of cyclin A2 mRNA through a nine-nucleotide essential sequence in cyclin A2 mRNA 3' UTR. WTAP knockdown induced G2 accumulation, which is partially rescued by adenoviral overexpression of cyclin A2. Moreover, WTAP-null mice exhibited proliferative failure with death resulting at approximately embryonic day 6.5, an etiology almost identical to cyclin A2-null mice. Collectively, these findings establish WTAP as an essential factor for the stabilization of cyclin A2 mRNA, thereby regulating G2/M cell-cycle transition.

Indexed as

Cell DivisionG2 Phase3' Untranslated RegionsAdenoviridaeAnimalsCarrier ProteinsCell Cycle ProteinsCells, CulturedChlorocebus aethiopsCyclin ADNA-Binding ProteinsEmbryo, MammalianGenotypeHumansMiceNuclear Proteins3' Untranslated RegionsCarrier ProteinsCell Cycle ProteinsCyclin ADNA-Binding ProteinsNuclear ProteinsRNA, MessengerRNA, Small InterferingRNA Splicing FactorsWTAP protein, humanWtap protein, mouse

Identifiers

PMID17088532
PMCPMC1634838
OpenAlexW2042898339

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.